Q-omics provides the consensus-scored MIR8087 profile across patient tissues and cancer cell-line models. MIR8087 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in COAD. Among the 18 cancer types available for tumor–normal comparison, MIR8087 is differentially expressed in 5, with the highest sampling consensus in THCA. Additionally, MIR8087 RNA expression shows 7,549 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight COAD, THCA, and UVM as cancer lineages where MIR8087 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for MIR8087 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes MIR8087 survival associations across molecular data types. MIR8087 RNA expression shows survival associations in the most cancer types (13). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible MIR8087 RNA expression–survival associations across cancer types. High MIR8087 expression shows unfavorable associations in COAD, PCPG, PAAD and KIRC, but favorable associations in KIRP and STAD. The COAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .002). Together, the overview and detailed table identify COAD as the clearest survival context for MIR8087 RNA expression.
This table summarizes MIR8087 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 5. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for MIR8087. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. MIR8087 shows lower tumor expression in THCA and KIRP and higher tumor expression in LUSC, LUAD and LIHC. The THCA box plot shows higher MIR8087 RNA expression in normal versus tumor tissue (log2 FC = −0.255, t-test p = .003).
This table shows molecular features associated with MIR8087 in patient tissues and cancer cell lines. In patient samples, MIR8087 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
